初级保健中测量腰围的价值:混合方法研究
结果显示全科医生记录腰围的发生率从2012年的每1000人年47例降至2023年的3例;在NEO研究中,测量腰围可识别89%的中危和93%的高危心血管风险患者。结论认为腰围测量可作为筛选适合心血管风险评估患者的工具。
要点
- 全科医生记录腰围的发生率从2012年47/1000人年降至2023年3/1000人年。
- 在NEO研究中,腰围测量可识别89%中危和93%高危预测心血管风险者。
- 腰围测量或可作为筛选心血管风险评估对象的简易工具,但需纳入指南并解决障碍。
核心结论
- 腰围测量可能作为有价值的筛查工具,用于筛选适合心血管风险评估的患者,以识别初级保健中心血管疾病风险增加者。
主要发现
- 2012至2023年间,全科医生记录腰围的发生率从每1000人年47例降至3例。
- 全科医生测量腰围的障碍包括不适感、无法准确测量、缺少卷尺和认为无用;促进因素包括了解腰围增加是心血管危险因素。
- 在NEO研究人群中,排除已接受心血管疾病预防治疗者(n=2407)后,1731例患者心血管疾病风险增加(n=1113中危,n=618高危)。
- 测量腰围可识别89%(993/1113)的中危预测心血管风险者和93%(575/618)的高危预测心血管风险者。
临床怎么用
- 全科医生可考虑将腰围测量作为筛选工具,用于确定哪些患者需要进一步心血管风险评估。
- 鉴于目前全科医生很少测量腰围,需将腰围测量纳入指南并针对已识别的障碍与促进因素采取干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It remains a challenge for GPs to identify all patients at increased risk of cardiovascular disease (CVD) in their practice, as performing cardiovascular risk assessment in every single patient is not feasible in routine practice. There is need for a simple tool to screen who is eligible for cardiovascular risk assessment and identify those at increased CVD risk. AIM: To investigate the value of measuring waist circumference in primary care by investigating: current recording practices of GPs; barriers and facilitators; and its contribution as a screening tool in the identification of patients at increased risk of CVD. DESIGN AND SETTING: A mixed-methods study was conducted in Dutch primary care. METHOD: We investigated the following three datasets: routine data from general practices (n = 676 708 health records of adults); qualitative data from six focus groups (n = 21 GPs); data from the Netherlands Epidemiology of Obesity (NEO) study (n = 6671 middle-aged individuals). RESULTS: Between 2012 and 2023, incidence rates of recorded waist circumference by GPs decreased from 47 to 3 per 1000 person-years. Barriers to GPs measuring waist circumference included discomfort, inability to measure it accurately, lack of measuring tape, and perceived uselessness. Facilitators included knowledge that increased waist circumference is a cardiovascular risk factor. In the NEO study population, after excluding patients already treated for the prevention of CVD (n = 2407), 1731 patients were at increased risk of CVD (n = 1113 intermediate risk, n = 618 high risk). Measuring waist circumference would identify 89% (993/1113) of those at intermediate and 93% (575/618) of those at high predicted cardiovascular risk. CONCLUSION: Waist circumference measurement may serve as a valuable screening tool to select patients eligible for cardiovascular risk assessment to identify those at increased risk of CVD in primary care. Since GPs currently rarely measure waist circumference, inclusion in guidelines and addressing identified barriers and facilitators is warranted.
引用
- van den Hout WJ, van Peet PG, Numans ME, et al. Value of measuring waist circumference in primary care: a mixed-methods study. Br J Gen Pract. 2026. PMID: 41592855. doi:10.3399/BJGP.2025.0395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。